GUPEA >
Sahlgrenska Academy / Sahlgrenska akademin >
Institute of Neuroscience and Physiology / Inst för neurovetenskap och fysiologi >
Doctoral Theses / Doktorsavhandlingar Institutionen för neurovetenskap och fysiologi >

The neuromodulatory effect, safety and effectiveness of vagus nerve stimulation


Please use this identifier to cite or link to this item: http://hdl.handle.net/2077/52044

Files in This Item:

File Description SizeFormat
gupea_2077_52044_3.pdfAbstract144KbAdobe PDF
View/Open
gupea_2077_52044_5.pdfCover1963KbAdobe PDF
View/Open
gupea_2077_52044_7.pdfThesis frame16770KbAdobe PDF
View/Open
Title: The neuromodulatory effect, safety and effectiveness of vagus nerve stimulation
Authors: Révész, David
E-mail: david.revesz@neuro.gu.se
Issue Date: 22-Mar-2017
University: University of Gothenburg. Sahlgrenska Academy
Institution: Institute of Neuroscience and Physiology. Department of Clinical Neuroscience and Rehabilitation
Parts of work: Revesz et al. Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation. Exp Neurol. 2008 Dec;214(2):259-65.
VIEW ARTICLE


Johannessen and Revesz et al. Vagal Blocking for Obesity Control: a Possible Mechanism-Of-Action.Obes Surg. 2017 Jan;27(1):177-185. Erratum in: Obes Surg. 2017 Jan;27(1):186.
VIEW ARTICLE


Révész et al. Complications and safety of vagus nerve stimulation: 25 years of experience at a single center. J Neurosurg Pediatr. 2016 Jul;18(1):97-104.
VIEW ARTICLE

Date of Defence: 2017-04-06
Disputation: Torsdagen den 6 april 2017, kl. 9.00, Hjärtats aula, Vita Stråket 12, Sahlgrenska Universitetssjukhuset, Göteborg
Degree: Doctor of Philosophy (Medicine)
Publication type: Doctoral thesis
Keywords: Vagus nerve stimulation
VNS
Neuromodulation
Neurogenesis
VBLOC
Epilepsy
Depression
Safety
Efficacy
Effectiveness
Abstract: Background Vagus nerve stimulation (VNS) is an adjunctive palliative neuromodulatory treatment for drug resistant epilepsy (DRE) and chronic depression. It has also been proposed as a treatment for many other conditions such as chronic pain, heart failure, and Alzheimer’s disease. Vagal Blocking Therapy (VBLOC) was recently approved for the treatment of obesity. However, the mechanisms of action still remains unclear and its long-term safety and efficacy in combination with antiepileptic ... more
ISBN: 978-91-629-0110-3 (PRINT)
978-91-629-0109-7 (PDF)
URI: http://hdl.handle.net/2077/52044
Appears in Collections:Doctoral Theses from Sahlgrenska Academy
Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet
Doctoral Theses / Doktorsavhandlingar Institutionen för neurovetenskap och fysiologi

 

 

© Göteborgs universitet 2011